Trial · NCT02607254
Results by group33
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 33
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Visual Analogue Score for Pain Intensity. | Pregabalin Treatment/Pregabalin Withdrawal | Basline | 7.1 | Standard Deviation 1.4 | score on visual analogue score |
| Visual Analogue Score for Pain Intensity. | Pregabalin Treatment/ Placebo Withdrawal | Basline | 6.9 | Standard Deviation 1.7 | score on visual analogue score |
| Visual Analogue Score for Pain Intensity. | Pregabalin Treatment/No Withdrwal | Basline | 7.3 | Standard Deviation 2.3 | score on visual analogue score |
| Visual Analogue Score for Pain Intensity. | Pregabalin Treatment/Pregabalin Withdrawal | After 8 weeks of Pregabalin | 5.4 | Standard Deviation 0.8 | score on visual analogue score |
| Visual Analogue Score for Pain Intensity. | Pregabalin Treatment/ Placebo Withdrawal | After 8 weeks of Pregabalin | 5.1 | Standard Deviation 1.1 | score on visual analogue score |
| Visual Analogue Score for Pain Intensity. | Pregabalin Treatment/No Withdrwal | After 8 weeks of Pregabalin | 7.6 | Standard Deviation 2.9 | score on visual analogue score |
| Visual Analogue Score for Pain Intensity. | Pregabalin Treatment/Pregabalin Withdrawal | After 4 weeks of Withdrawal phase | 6.1 | Standard Deviation 1.2 | score on visual analogue score |
| Visual Analogue Score for Pain Intensity. | Pregabalin Treatment/ Placebo Withdrawal | After 4 weeks of Withdrawal phase | 7.4 | Standard Deviation 1.8 | score on visual analogue score |
| Visual Analogue Score for Pain Intensity. | Pregabalin Treatment/No Withdrwal | After 4 weeks of Withdrawal phase | NA | Standard Deviation NA | score on visual analogue score |
| Brief Pain Inventory (BPI sf); | Pregabalin Treatment/Pregabalin Withdrawal | Basline | 6.7 | Standard Deviation 0.9 | score in brief pain inventory scale |
| Brief Pain Inventory (BPI sf); | Pregabalin Treatment/ Placebo Withdrawal | Basline | 6.3 | Standard Deviation 1.1 | score in brief pain inventory scale |
| Brief Pain Inventory (BPI sf); | Pregabalin Treatment/No Withdrwal | Basline | 7.2 | Standard Deviation 1.3 | score in brief pain inventory scale |
| Brief Pain Inventory (BPI sf); | Pregabalin Treatment/Pregabalin Withdrawal | After 8 weeks of Pregabalin | 4.9 | Standard Deviation 1.1 | score in brief pain inventory scale |
| Brief Pain Inventory (BPI sf); | Pregabalin Treatment/ Placebo Withdrawal | After 8 weeks of Pregabalin | 4.5 | Standard Deviation 1.4 | score in brief pain inventory scale |
| Brief Pain Inventory (BPI sf); | Pregabalin Treatment/No Withdrwal | After 8 weeks of Pregabalin | 6.8 | Standard Deviation 1.7 | score in brief pain inventory scale |
| Brief Pain Inventory (BPI sf); | Pregabalin Treatment/Pregabalin Withdrawal | After 4 weeks of Withdrawal phase | 5.8 | Standard Deviation 2.1 | score in brief pain inventory scale |
| Brief Pain Inventory (BPI sf); | Pregabalin Treatment/ Placebo Withdrawal | After 4 weeks of Withdrawal phase | 5.6 | Standard Deviation 1.9 | score in brief pain inventory scale |
| Brief Pain Inventory (BPI sf); | Pregabalin Treatment/No Withdrwal | After 4 weeks of Withdrawal phase | NA | Standard Deviation NA | score in brief pain inventory scale |
| Sleep Quality as Assessed by Daily Sleep Interference Rating Scale (SIRS); | Pregabalin Treatment/Pregabalin Withdrawal | Basline | 4.5 | Standard Deviation 0.3 | score on Sleep Interference Rating scale |
| Sleep Quality as Assessed by Daily Sleep Interference Rating Scale (SIRS); | Pregabalin Treatment/ Placebo Withdrawal | Basline | 5.3 | Standard Deviation 0.61 | score on Sleep Interference Rating scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02607254/results